Pdt Partners, LLC Rhythm Pharmaceuticals, Inc. Transaction History
Pdt Partners, LLC
- $1.58 Billion
- Q2 2025
A detailed history of Pdt Partners, LLC transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Pdt Partners, LLC holds 97,638 shares of RYTM stock, worth $9.79 Million. This represents 0.39% of its overall portfolio holdings.
Number of Shares
97,638
Previous 102,195
4.46%
Holding current value
$9.79 Million
Previous $5.41 Million
13.97%
% of portfolio
0.39%
Previous 0.42%
Shares
9 transactions
Others Institutions Holding RYTM
# of Institutions
254Shares Held
66.8MCall Options Held
210KPut Options Held
575K-
Black Rock Inc. New York, NY6.74MShares$676 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY5.6MShares$562 Million3.59% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.56MShares$558 Million7.68% of portfolio
-
Vanguard Group Inc Valley Forge, PA5MShares$501 Million0.01% of portfolio
-
Primecap Management CO Pasadena, CA4.88MShares$489 Million0.25% of portfolio
About RHYTHM PHARMACEUTICALS, INC.
- Ticker RYTM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,720,000
- Market Cap $5.59B
- Description
- Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...